Hearing Health Foundation

Hearing Health Foundation company information, Employees & Contact Information

The mission of Hearing Health Foundation (HHF) is to prevent and cure hearing loss and tinnitus through groundbreaking research and to promote hearing health. HHF is the largest nonprofit funder of hearing and balance research in the U.S. and a leader in driving new innovations and treatments for people with hearing loss, tinnitus, and other hearing disorders.
Looking for a particular Hearing Health Foundation employee's phone or email?

Hearing Health Foundation Questions

News

Healthy Housing Fdn Continues Multi-Million-Dollar Commitment to Access to Housing - AIDS Healthcare Foundation

Healthy Housing Fdn Continues Multi-Million-Dollar Commitment to Access to Housing AIDS Healthcare Foundation

Angeline Spaulding Obituary (2025) - Kingston, PA - Times Leader - Legacy obituary

Angeline Spaulding Obituary (2025) - Kingston, PA - Times Leader Legacy obituary

Clinical Management and Transplant Considerations in Pediatric Pulmonary Hypertension Due to Left Heart Disease: A Scientific Statement From the American Heart Association | Circulation: Heart Failure - American Heart Association Journals

Clinical Management and Transplant Considerations in Pediatric Pulmonary Hypertension Due to Left Heart Disease: A Scientific Statement From the American Heart Association | Circulation: Heart Failure American Heart Association Journals

Sulfonated Poly(fluorene alkylene)s Containing Dual Hydrophilic and Hydrophobic Side Chains for High-Performance Proton Exchange Membranes - ACS Publications

Sulfonated Poly(fluorene alkylene)s Containing Dual Hydrophilic and Hydrophobic Side Chains for High-Performance Proton Exchange Membranes ACS Publications

Hearing Health Foundation a Trustworthy Choice in an Era of American Skepticism - PR Newswire

Hearing Health Foundation a Trustworthy Choice in an Era of American Skepticism PR Newswire

AT&T and the Hispanic Heritage Foundation Address the Digital Divide - AT&T Newsroom

AT&T and the Hispanic Heritage Foundation Address the Digital Divide AT&T Newsroom

Hospitalization for Heart Failure and Subsequent Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction - ScienceDirect.com

Hospitalization for Heart Failure and Subsequent Ventricular Tachyarrhythmias in Patients With Left Ventricular Dysfunction ScienceDirect.com

Hearing Health Foundation Launches ‘Faces of Hearing Loss’ Campaign - The Hearing Review

Hearing Health Foundation Launches ‘Faces of Hearing Loss’ Campaign The Hearing Review

Pulmonary Hypertension in Congenital Heart Disease: A Scientific Statement From the American Heart Association - American Heart Association Journals

Pulmonary Hypertension in Congenital Heart Disease: A Scientific Statement From the American Heart Association American Heart Association Journals

The Hearing Health Foundation Releases Emergency Preparedness Guide for Hearing Impaired - The Hearing Review

The Hearing Health Foundation Releases Emergency Preparedness Guide for Hearing Impaired The Hearing Review

Editors and Editorial Board | Circulation: Heart Failure - American Heart Association Journals

Editors and Editorial Board | Circulation: Heart Failure American Heart Association Journals

Heart Failure Management in Skilled Nursing Facilities: - American Heart Association Journals

Heart Failure Management in Skilled Nursing Facilities: American Heart Association Journals

Pulmonary Hypertension in Congenital Heart Disease: A Scientific Statement From the American Heart Association - American Heart Association Journals

Pulmonary Hypertension in Congenital Heart Disease: A Scientific Statement From the American Heart Association American Heart Association Journals

Association of Ischemic Evaluation and Clinical Outcomes Among Patients Admitted With New‐Onset Heart Failure - American Heart Association Journals

Association of Ischemic Evaluation and Clinical Outcomes Among Patients Admitted With New‐Onset Heart Failure American Heart Association Journals

So Much to Say on the Best of What's Around Regarding Sodium‐Glucose Cotransporter‐2 Inhibitors in Acute Myocardial Infarction - American Heart Association Journals

So Much to Say on the Best of What's Around Regarding Sodium‐Glucose Cotransporter‐2 Inhibitors in Acute Myocardial Infarction American Heart Association Journals

Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study) - American Heart Association Journals

Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study) American Heart Association Journals

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus | Circulation - American Heart Association Journals

Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus | Circulation American Heart Association Journals

Notice of Retraction - American Heart Association Journals

Notice of Retraction American Heart Association Journals

Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial | Circulation - American Heart Association Journals

Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial | Circulation American Heart Association Journals

Joan Beck Obituary - Sandy Springs, GA - Dignity Memorial

Joan Beck Obituary - Sandy Springs, GA Dignity Memorial

Zebulon Beck Obituary - Sandy Springs, GA - Dignity Memorial

Zebulon Beck Obituary - Sandy Springs, GA Dignity Memorial

Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial - ScienceDirect.com

Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced Trial ScienceDirect.com

Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction | Circulation - American Heart Association Journals

Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction | Circulation American Heart Association Journals

Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus | Circulation - American Heart Association Journals

Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus | Circulation American Heart Association Journals

Patients With Type 2 Diabetes Mellitus and Heart Failure Benefit More From Sodium-Glucose Cotransporter 2 Inhibitor: A Systematic Review and Meta-Analysis - Frontiers

Patients With Type 2 Diabetes Mellitus and Heart Failure Benefit More From Sodium-Glucose Cotransporter 2 Inhibitor: A Systematic Review and Meta-Analysis Frontiers

Capitals, MSE Foundation to Celebrate Hispanic Heritage Month - NHL.com

Capitals, MSE Foundation to Celebrate Hispanic Heritage Month NHL.com

Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA‐CKD Trial - American Heart Association Journals

Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA‐CKD Trial American Heart Association Journals

Effect of Vericiguat on Total Heart Failure Events in Compensated Outpatients With HFrEF: Insights From VICTOR - JACC Journals

Effect of Vericiguat on Total Heart Failure Events in Compensated Outpatients With HFrEF: Insights From VICTOR JACC Journals

Comparison of simultaneous saccharification and fermentation with LPMO-supported hybrid hydrolysis and fermentation - Frontiers

Comparison of simultaneous saccharification and fermentation with LPMO-supported hybrid hydrolysis and fermentation Frontiers

Real-world experience of angiotensin receptor-neprilysin inhibitors in patients with heart failure and dialysis - Frontiers

Real-world experience of angiotensin receptor-neprilysin inhibitors in patients with heart failure and dialysis Frontiers

SGLT ‐2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects - American Heart Association Journals

SGLT ‐2 Inhibitors in Heart Failure: Current Management, Unmet Needs, and Therapeutic Prospects American Heart Association Journals

Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14 - BioMed Central

Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14 BioMed Central

Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity - American Heart Association Journals

Independent Prognostic Value of Serum Soluble ST2 Measurements in Patients With Heart Failure and a Reduced Ejection Fraction in the PARADIGM-HF Trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity American Heart Association Journals

Cardiovascular outcomes and safety of SGLT2 inhibitors in chronic kidney disease patients - Frontiers

Cardiovascular outcomes and safety of SGLT2 inhibitors in chronic kidney disease patients Frontiers

Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction: Insights From REVIVED-BCIS2 - ScienceDirect.com

Effect of PCI on Health Status in Ischemic Left Ventricular Dysfunction: Insights From REVIVED-BCIS2 ScienceDirect.com

Molecular engineering of safe and efficacious oral basal insulin - Nature

Molecular engineering of safe and efficacious oral basal insulin Nature

Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure | Circulation - American Heart Association Journals

Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure | Circulation American Heart Association Journals

Landskronhof Apartments / HHF Architects - ArchDaily

Landskronhof Apartments / HHF Architects ArchDaily

Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved - Nature

Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved Nature

Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER | Circulation - American Heart Association Journals

Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER | Circulation American Heart Association Journals

Heart Failure Drug Treatment—Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF) - ScienceDirect.com

Heart Failure Drug Treatment—Inertia, Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF) ScienceDirect.com

AHF Career Opportunities - AIDS Healthcare Foundation

AHF Career Opportunities AIDS Healthcare Foundation

HHF: East L.A.’s ‘Casa Del Corazon’ Reborn as Homeless Housing - AIDS Healthcare Foundation

HHF: East L.A.’s ‘Casa Del Corazon’ Reborn as Homeless Housing AIDS Healthcare Foundation

A mixed-methods pilot study of handheld fan for breathlessness in interstitial lung disease - Nature

A mixed-methods pilot study of handheld fan for breathlessness in interstitial lung disease Nature

Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium–glucose co-transporter 2 inhibitor therapy in DECLARE-TIMI 58 - Wiley Online Library

Relationship between baseline cardiac biomarkers and cardiovascular death or hospitalization for heart failure with and without sodium–glucose co-transporter 2 inhibitor therapy in DECLARE-TIMI 58 Wiley Online Library

Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes - JACC Journals

Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes JACC Journals

Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management - BioMed Central

Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management BioMed Central

Size-matched hydrogen bonded hydroxylammonium frameworks for regulation of energetic materials - Nature

Size-matched hydrogen bonded hydroxylammonium frameworks for regulation of energetic materials Nature

John M. Ferguson Obituary December 17, 2017 - New Comer Cremations & Funerals

John M. Ferguson Obituary December 17, 2017 New Comer Cremations & Funerals

Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes - BioMed Central

Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes BioMed Central

Nationwide, Hispanic Heritage Foundation Announce 2021 Financial Empowerment Charlas Series - Nationwide Mutual Insurance Company

Nationwide, Hispanic Heritage Foundation Announce 2021 Financial Empowerment Charlas Series Nationwide Mutual Insurance Company

98-Year-Old Olympic Hotel Reborn as AHF Low-Income Housing Property - AIDS Healthcare Foundation

98-Year-Old Olympic Hotel Reborn as AHF Low-Income Housing Property AIDS Healthcare Foundation

Delayed insulin absorption correlates with alterations in subcutaneous depot kinetics in rats with diet-induced obesity - Wiley Online Library

Delayed insulin absorption correlates with alterations in subcutaneous depot kinetics in rats with diet-induced obesity Wiley Online Library

Differences in outcomes of hospitalizations for heart failure after SGLT2 inhibitor treatment: effect modification by atherosclerotic cardiovascular disease - BioMed Central

Differences in outcomes of hospitalizations for heart failure after SGLT2 inhibitor treatment: effect modification by atherosclerotic cardiovascular disease BioMed Central

Sodium-Glucose Cotransporter-2 Inhibitors and Cardiovascular Protection Among Patients With Type 2 Diabetes Mellitus: A Systematic Review - Wiley Online Library

Sodium-Glucose Cotransporter-2 Inhibitors and Cardiovascular Protection Among Patients With Type 2 Diabetes Mellitus: A Systematic Review Wiley Online Library

Healthy Housing Foundation Buys 2 Skid Row Properties in L.A. to Build New Affordable Housing - AIDS Healthcare Foundation

Healthy Housing Foundation Buys 2 Skid Row Properties in L.A. to Build New Affordable Housing AIDS Healthcare Foundation

HHF Architekten uses modular steel and timber structure for mixed-use block in Switzerland - Dezeen

HHF Architekten uses modular steel and timber structure for mixed-use block in Switzerland Dezeen

AHF creates affordable housing - Dallas Voice

AHF creates affordable housing Dallas Voice

Human hair follicle-derived mesenchymal stem cells: Isolation, expansion, and differentiation - Baishideng Publishing Group

Human hair follicle-derived mesenchymal stem cells: Isolation, expansion, and differentiation Baishideng Publishing Group

“Well Done” - Adventist Review

“Well Done” Adventist Review

2019 Hispanic Heritage Awards | Friday, October 11 at 10 pm - WOUB Public Media -

2019 Hispanic Heritage Awards | Friday, October 11 at 10 pm WOUB Public Media -

Guesthouse / HHF architects + Ai Weiwei - ArchDaily

Guesthouse / HHF architects + Ai Weiwei ArchDaily

Comparing angiotensin receptor–neprilysin inhibitors with sodium–glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus - Diabetology & Metabolic Syndrome

Comparing angiotensin receptor–neprilysin inhibitors with sodium–glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus Diabetology & Metabolic Syndrome

Human neural stem cell-derived extracellular vesicles protect against Parkinson’s disease pathologies - Journal of Nanobiotechnology

Human neural stem cell-derived extracellular vesicles protect against Parkinson’s disease pathologies Journal of Nanobiotechnology

Poissy Galore / HHF Architects + AWP - ArchDaily

Poissy Galore / HHF Architects + AWP ArchDaily

HHF architects: ruta del peregrino construction - Designboom

HHF architects: ruta del peregrino construction Designboom

House D / HHF Architects - ArchDaily

House D / HHF Architects ArchDaily

Top Hearing Health Foundation Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant